<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR180">
 <label>180.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ding</surname>
    <given-names>Changhai</given-names>
   </name>
  </person-group>
  <article-title>Belimumab, an anti-BLyS human monoclonal antibody for potential treatment of inflammatory autoimmune diseases</article-title>
  <source>Expert Opinion on Biological Therapy</source>
  <year>2008</year>
  <volume>8</volume>
  <issue>11</issue>
  <fpage>1805</fpage>
  <lpage>1814</lpage>
  <pub-id pub-id-type="doi">10.1517/14712598.8.11.1805</pub-id>
  <?supplied-pmid 18847314?>
  <pub-id pub-id-type="pmid">18847314</pub-id>
 </element-citation>
</ref>
